Delta變體：自然免疫能力比疫苗高700%
Delta Variant: Natural Immunity 700% Better Than the Vaccine
Delta變體：自然免疫能力比疫苗高700%！- Era of Light
Posted on 07/29/2021
by EraOfLight
發佈於2021年7月29日
作者：Era of Light
Editor’s Commentary: Let’s start with the biggest question that is not getting adequately answered by anyone in government, mainstream media, academia, or Big Pharma. Why is natural immunity to Covid-19 being disregarded completely? It’s not just getting ignored. The powers-that-be are actively and aggressively quashing every question, “debunking” every study, and torturing every number they can get their hands on in order to make them say what they want.
編者按：讓我們從政府、主流媒體、學術界或大型製藥企業中沒有得到充分回答的最大問題開始。為什麼對Covid-19的自然免疫力被完全忽視了？這不僅僅是被忽視。當權者正在積極主動地駁斥每一個問題，“揭穿”每一項研究，折磨每一個他們能得到的數字，以便讓他們說出他們想要的。
The agenda to drive universal vaccinations of the populace has forced them into a corner when it comes to the question of natural immunity. They can’t say it’s not a reasonable question, nor can they say it’s already been answered properly. They just say this organization or that doctor or some study shows that even those with natural immunity must still get vaccinated.
在自然免疫問題上，推動全民接種疫苗的議程迫使他們陷入困境。他們不能說這不是一個合理的問題，也不能說已經得到了正確的回答。他們只是說這個組織、那個醫生或一些研究表明，即使是那些具有自然免疫力的人也必須接種疫苗。
When pressed, they invoke the logical fallacy known as begging the question; they use the affirmative answer to the question of whether people who have recovered from Covid-19 should get vaccinated as the evidence that they should.
當被追問時，他們會引用邏輯謬論，即所謂的乞求問題；他們用對新冠病毒感染者是否應該接種疫苗的肯定回答作為他們應該接種疫苗的證據。
The numbers don’t back up this claim, though studies have been limited due to pressure from the powers-that-be. Logic doesn’t support the claims, either, as only an infinitesimal percentage of people who have recovered from Covid-19 have become infected again. Science definitely does not back the claim since literally every known virus prior to Covid-19 has been better-prevented by natural immunity than vaccines.
這些數字並不支持這一說法，儘管由於來自當權者的壓力，研究受到限制。邏輯也不支持這種說法，因為只有極少數從Covid-19中康復的人再次感染。科學肯定不支持這一說法，因為事實上，在Covid-19之前，每一種已知病毒都可以通過自然免疫比疫苗更好地預防。
This last point is important because it brings up the original necessity for vaccines of the past. The only times vaccines were deemed necessary were when a viral infection had a poor recovery rate. Polio, for example, was simply too potentially dangerous for people to rely on natural immunity. Sure, those who recovered were protected, but a large percentage of people who contracted polio had reasonable fears of death or debilitation. Covid-19 has a 99.97% recovery rate for otherwise healthy people under 50.
最後一點很重要，因為它提出了過去疫苗的原始必要性。只有當病毒感染的恢復率很低時，疫苗才被認為是必要的。例如，脊髓灰質炎對人們來說太危險了，無法依靠自然免疫。當然，那些康復者得到了保護，但感染脊髓灰質炎的人中有很大一部分人對死亡或虛弱有合理的恐懼。對於50歲以下的健康人
群，Covid-19的恢復率為99.97%。
Sometimes, vaccines are able to get close to the efficacy of natural immunity. Covid-19 is not one of those cases. As Dr. Joseph Mercola details below, natural immunity is so extraordinarily superior to vaccine immunity that one should question whether vaccinating those who have recovered from Covid-19 actually does more harm than good.
有時，疫苗能夠接近自然免疫的效果。Covid-19不是這些病例之一。正如Joseph Mercola博士在下面詳述的那樣，自然免疫比疫苗免疫更優越，因此人們應該質疑，為那些從COVID-19中恢復的人接種疫苗是否真的弊大於利。
I’m not just talking about the astronomical number of adverse reactions reported to VAERS, now approaching 500,000. I’m referring to studies that have shown vaccinated people who already have natural immunity may actually increase their chances of getting it again by essentially confusing the body into creating weaker resistance to the coronavirus.
我現在所說的不良反應已經接近500個了，我指的是一些研究表明，已經接種過疫苗的人，如果他們已經有了自然免疫力，實際上可能會增加他們再次感染的機會，因為他們基本上混淆了身體對冠狀病毒的抵抗力。
The powers-that-be may torture the numbers to become statistics that fit their agenda, but the raw data doesn’t lie. That’s why it’s shocking so few have reported on the clearly higher efficacy of natural immunity, particularly against the Delta Variant, over vaccines.
當權者可能會折磨這些數字，使之成為符合他們議程的統計數據，但原始數據並不存在。這就是為什麼令人震驚的是，很少有人報導自然免疫的效果明顯高於疫苗，特別是針對Delta變體。
We actually covered this before, though not nearly as authoritatively as Dr. Mercola does below. But here’s the thing, and it’s extremely important to understand. Those of us who are fighting for the truth need to be repetitive. We need to hammer home the message, and if that means taking each individual topic and hammering it home a dozen times a week, so be it.
事實上，我們之前已經討論過這個問題，儘管不像下面Mercola博士那樣權威。但問題是，理解這一點非常重要。我們這些為真理而戰的人需要重複。我們需要把信息傳達給大家，如果這意味著要把每一個話題都傳達給大家，一周要傳達十幾次，那就這樣吧。
Those who are pushing vaccines have no problem telling us every hour of every day how silly we are for asking questions. When we get answers such as those offered below, we must keep pushing it out to all who will listen.
那些正在推廣疫苗的人毫無疑問每天每小時都會告訴我們，我們問問題是多麼愚蠢。當我們得到下面提供的答案時，我們必須不斷向所有願意傾聽的人公佈。
The people need to hear the truth over and over again because I can assure you they’re hearing the drumbeat of lies incessantly. With the Delta Variant, the long list of lies continues to expand. We need facts to be broadcast loud and clear. To that end, here’s Dr. Mercola…
人們需要一次又一次地聽到真相，因為我可以向你保證，他們不斷地聽到謊言的鼓聲。隨著Delta變體的出現，謊言的列表不斷擴大。我們需要把事實大聲清楚地傳播出去。為此，梅科拉博士…
Story at-a-Glance ~
故事一覽 ~
▪︎ Data presented to the Israeli Health Ministry July 17, 2021, revealed that, of the more than 7,700 COVID-19 cases reported since May 2021, only 72 occurred in people who had previously had COVID-19 — a rate of less than 1%
▪︎ 2021年7月17日提交給以色列衛生部的數據顯示，自2021年5月以來報告的7700多例COVID-19病例中，只有72例發生在先前患有新冠病毒-19的人群中，發病率不到1%
▪︎ In contrast, more than 3,000 cases — or approximately 40% — occurred in people who had received a COVID-19 vaccine
▪︎ 相比之下，接受過COVID-19疫苗的人群中發生了3000多例（約40%）
▪︎ In other words, those who were vaccinated were nearly 700% more likely to develop COVID-19 than those who had natural immunity from a prior infection — and this is largely in response to the Delta variant, which has led to increasing infections in Israel
▪︎ 換句話說，接種疫苗的人比那些對先前感染具有自然免疫力的人患COVID-19的可能性高出近700%——這主要是對Delta變體的反
應，Delta變體導致以色列的感染增加
▪︎ It’s extremely rare to get reinfected by COVID-19 after you’ve already had the disease and recovered; one study found the median reinfection rate was just 0.27%
▪︎ 在你已經患上COVID-19並痊癒後，再感染COVID-19是極其罕見的；一項研究發現中位再感染率僅為0.27%
▪︎ With effective treatments available, the documented high survival rate of COVID-19 and knowledge that if you’ve had COVID-19, you’re already likely immune to further infection, the rationale for getting vaccinated is faltering
▪︎ 有了有效的治療手段，有文獻記載的COVID-19的高存活率，以及如果你已經感染了COVID-19，你可能已經對進一步的感染產生了免疫力，接種疫苗的理由正在動搖
…………………………………………………………
A recurring theme being broadcast by public health officials and the media is that vaccine-induced immunity is superior to that of natural immunity, but preliminary data from Israel — a country with more than 60% of its population vaccinated against COVID-19 (1) — is showing otherwise.
公共衛生官員和媒體反複播出的一個主題是，疫苗誘導免疫優於自然免疫，但來自以色列的初步數據——該國60%以上的人口接種了COVID-19（1）——卻顯示了相反的結果。
Data presented to the Israeli Health Ministry July 13, 2021, (2) revealed that, of the more than 7,700 COVID-19 cases reported since May 2021, only 72 occurred in people who had previously had COVID-19 — a rate of less than 1%. In contrast, more than 3,000 cases — or approximately 40% — occurred in people who had received a COVID-19 vaccine. As reported by Israeli National News:
2021年7月13日提交給以色列衛生部的數據（2）顯示，自2021年5月以來報告的7700多例COVID-19病例中，只有72例發生在先前患有新冠病毒-19的人群中，發病率不到1%。相比之下，接受過COVID-19疫苗的人群中發生了3000多例（約40%）。據以色列國家新聞報導：
“With a total of 835,792 Israelis known to have recovered from the virus, the 72 instances of reinfection amount to 0.0086% of people who were already infected with COVID.
“已知總共有835792名以色列人已從病毒中康復，72例再感染病例佔已感染COVID-19人群的0.0086%。
By contrast, Israelis who were vaccinated were 6.72 times more likely to get infected after the shot than after natural infection, with over 3,000 of the 5,193,499, or 0.0578%, of Israelis who were vaccinated getting infected in the latest wave.”
相比之下，接種疫苗的以色列人在注射後感染的可能性是自然感染後的6.72倍，在5193499人中，有3000多人，或0.0578%的以色列人在最新一波接種疫苗後感染。”
In other words, those who were vaccinated were nearly 700% more likely to develop COVID-19 than those who had natural immunity from a prior infection — and this is largely in response to the Delta variant, which has led to increasing infections in Israel. (3)
換句話說，接種疫苗的人比那些對先前感染具有自然免疫力的人患COVID-19的可能性高出近700%——這主要是對Delta變體的反應，Delta變異導致以色列的感染增加(3)
Rate of COVID Reinfection: 0.27%
COVID-19再次感染率：0.27%
It’s extremely rare to get reinfected by COVID-19 after you’ve already had the disease and recovered. How rare? Researchers from Ireland conducted a systematic review including 615,777 people who had recovered from COVID-19, with a maximum duration of follow-up of more than 10 months. (4)
在你已經患上新冠病毒並痊癒後，再感染COVID-19是極其罕見的。有多罕見？來自愛爾蘭的研究人員對615777名從COVID-19中康復的人進行了系統回顧，最長隨訪時間超過10個月(4)
“Reinfection was an uncommon event,” they noted, “… with no study reporting an increase in the risk of reinfection over time.” The absolute reinfection rate ranged from 0% to 1.1%, while the median reinfection rate was just 0.27%.(5,6,7)
“再感染是一個罕見的事件，”他們指出，“……沒有研究報告再感染風險隨時間增加。”絕對再感染率在0%到1.1%之間，而中位再感染率僅為0.27%。（5,6,7）
Another study revealed similarly reassuring results. It followed 43,044 SARS-CoV-2 antibody-positive people for up to 35 weeks, and only 0.7% were reinfected. When genome sequencing was applied to estimate population-level risk of reinfection, the risk was estimated at 0.1%.(8)
另一項研究顯示了類似的令人放心的結果。它對43044名SARS-CoV-2抗體陽性者進行了長達35週的隨訪，只有0.7%的人再次感染。當基因組測序用於估計人群再次感染的風險時，風險估計為0.1%。（8）
Again, there was no indication of waning immunity over seven months of follow-up, with the researchers concluding, “Reinfection is rare. Natural infection appears to elicit strong protection against reinfection with an efficacy >90% for at least seven months.”(9)
同樣，在7個月的隨訪中，沒有跡象表明免疫力下降，研究人員得出結論：“再感染是罕見的。自然感染似乎能引起對再次感染的強烈保護，至少七個月的療效>90%。”（9）
Another study from Israel also had researchers questioning “the need to vaccinate previously-infected individuals,” after their analysis showed similar risks of reinfection among those with vaccine-induced or natural immunity. Specifically, vaccination had an overall estimated efficacy of preventing reinfection of 92.8%, compared to 94.8% for natural immunity acquired via prior infection.(10)
來自以色列的另一項研究也讓研究人員質疑“為先前感染的個體接種疫苗的必要性”，因為他們的分析顯示，在疫苗誘導或自然免疫的人群中，再次感染的風險相似。具體而言，疫苗接種預防再次感染的總體估計有效率為92.8%，相比之下，通過先前感染獲得的自然免疫的有效率為94.8%
Why Natural Immunity Is Superior
為什麼自然免疫力優越
Speaking with journalist Daniel Horowitz, pathologist Dr. Ryan Cole explained that natural immunity produces broad immunity that can’t be matched by vaccination:(11)
病理學家Ryan Cole博士在接受記者Daniel Horowitz採訪時解釋說，自然免疫產生廣泛的免疫，這是疫苗接種所無法比擬的：（11）
“A natural infection induces hundreds upon hundreds of antibodies against all proteins of the virus, including the envelope, the membrane, the nucleocapsid, and the spike. Dozens upon dozens of these antibodies neutralize the virus when encountered again.
“自然感染會誘導成百上千的抗體對抗病毒的所有蛋白質，包括包膜，膜，核衣殼，還有尖峰。當再次遇到病毒時，數十種這種抗體可以中和病毒。
Additionally, because of the immune system exposure to these numerous proteins (epitomes), our T cells mount a robust memory, as well. Our T cells are the ‘marines’ of the immune system and the first line of defense against pathogens. T cell memory to those infected with SARSCOV1 is at 17 years and running still.”
此外，由於免疫系統暴露於這些眾多的蛋白質（表位），我們的T細胞也具有強大的記憶能力。我們的T細胞是免疫系統的“海軍陸戰隊”，是抵禦病原體的第一道防線。SARSCOV1感染者的T細胞記憶已達17年，且仍在運行。”
In 2020 it was reported that people who had recovered from SARS-CoV — a virus that is genetically closely related to SARS-CoV-2 and belongs to the same viral species — maintained significant levels of neutralizing antibodies at least 17 years after initial infection.(12) This also suggests that long-term natural immunity against SARS-CoV-2 should be expected.(13)
據報導，在2020年，從SARS-CoV（一種與SARS-CoV-2基因密切相關且屬於同一病毒種類的病毒）中康復的人在初次感染後至少17年內保持了顯著水平的中和抗體。（12）這也表明對SARS-CoV-2的長期自然免疫應該是意料之中的
With vaccination, however, Israeli (14) data suggest that those who were vaccinated early on, in January 2021, are becoming susceptible to the virus, suggesting its efficacy may wane after about six months.
然而，在接種疫苗的情況下，以色列（14）的數據表明，那些在2021年1月早期接種疫苗的人對該病毒越來越敏感，表明其效力可能在大約六個月後減弱。
This sentiment was echoed by Pfizer’s head of medical research and development, Mikael Dolsten, who said “after six months, there may be risk of infection with the expected decline of antibodies.” Pfizer is seeking emergency use authorization for a third booster dose of its COVID-19 vaccine in the U.S.(15)
輝瑞醫藥研發負責人米凱爾·多爾斯滕（Mikael Dolsten）也表達了這種觀點，他說“六個月後，抗體預期下降，可能會有感染的風險。”輝瑞正在尋求在美國緊急使用第三劑增強劑的COVID-19疫苗的授權。（15）
According to Cole, part of the reason for waning vaccine-induced immunity is because “we mount an antibody response to only the spike and its constituent proteins” and “as the virus preferentially mutates at the spike, these proteins are shaped differently and antibodies can no longer ‘lock and key’ bind to these new shapes.”(16)
科爾認為，疫苗誘導免疫力下降的部分原因是“我們只對尖峰及其組成蛋白產生抗體反應”，“由於病毒在尖峰處優先突變，這些蛋白的形狀不同，抗體不能再“鎖定”這些新形狀。”（16）
Natural COVID Immunity May Last a Lifetime
自然的COVID免疫可能持續一生
It was initially suggested that natural COVID-19 immunity may be short-lived. This was based on early data on SARS-CoV-2, which found that antibody titers declined rapidly in the first months after recovery from COVID-19. According to a team of researchers from the Washington University School of Medicine, however, if you’ve had COVID-19 — even a mild case — you’re likely to be immune for life, as is the case with recovery from many infectious agents.(17)
最初有人認為，自然的COVID-19免疫可能是短暫的。這是基於SARS COV-2的早期數據，它發現抗體滴度在COVID-19恢復後的第一個月迅速下降。然而，根據華盛頓大學醫學院的一組研究人員，如果你有COVID-19——即使是輕微的病例——你很可能對生命免疫，就像從許多傳染源中恢復一樣
According to senior author of the study Ali Ellebedy, Ph.D., an associate professor of pathology and immunology at Washington University School of Medicine in St. Louis, “It’s normal for antibody levels to go down after acute infection, but they don’t go down to zero; they plateau.”(18)
根據該研究的資深作者Ali Ellebedy，博士，路易斯華盛頓大學醫學院病理學和免疫學的副教授，“抗體水平在急性感染後下降是正常的，但它們不會下降到零；它們是高原。”（18）
The researchers found a biphasic pattern of antibody concentrations against SARS-CoV-2, in which high antibody concentrations were found in the acute immune response that occurred at the time of initial infection. The antibodies declined in the first months after infection, as should be expected, then leveled off to about 10% to 20% of the maximum concentration detected.
研究人員發現了一種針對SARS-CoV-2的雙相抗體濃度模式，在最初感染時的急性免疫反應中發現了高抗體濃度。正如預期的那樣，抗體在感染後的頭幾個月下降，然後穩定到最高檢測濃度的10%到20%左右。
When a new infection occurs, cells called plasmablasts provide antibodies, but when the virus is cleared, longer lasting memory B cells move in to monitor blood for signs of reinfection.(19) Bone marrow plasma cells (BMPCs) also exist in bones, acting as “persistent and essential sources of protective antibodies.”(20) Ellebedy even said the protection provided by naturally acquired immunity is likely to continue “indefinitely”:(21)
當新的感染發生時，稱為漿細胞的細胞提供抗體，但當病毒被清除後，持續時間更長的記憶B細胞進入血液，以監測再感染的跡象。（19）骨髓漿細胞（BMPC）也存在於骨骼中，作為“保護性抗體的持久和基本來源”。（20）Ellebedy甚至說，自然獲得的免疫所提供的保護可能會“無限期地”繼續下去：
“These [BMPC] cells are not dividing. They are quiescent, just sitting in the bone marrow and secreting antibodies. They have been doing that ever since the infection resolved, and they will continue doing that indefinitely.”
“這些[BMPC]細胞沒有分裂。它們是靜止的，只是坐在骨髓中分泌抗體。自從感染解決以來，他們一直在這樣做，而且他們將無限期地繼續這樣做。”
In another explanation of why antibody levels drop after initial infection — but it’s not an indication of waning immunity — Cole told Horowitz:(22)
科爾告訴霍洛維茨：（22）在另一種解釋中，為什麼最初感染後抗體水平下降——但這並不是免疫力下降的跡象
“Yes, our antibody levels drop over time, however, scientifically, the memory B cells that make antibodies have been proven to be present in our lymph nodes and bone marrow. They are primed and ready to produce a broad array of antibodies upon viral pre-exposure.
“是的，我們的抗體水平會隨著時間的推移而下降，然而，科學證明，製造抗體的記憶B細胞存在於我們的淋巴結和骨髓中。它們經過預處理，在病毒預暴露時可產生廣泛的抗體。
It would be physiologically, energetically impossible to maintain high antibody levels to all the pathogens we are constantly exposed to, and we would look like the ‘swollen Stay-Puft marshmallow man’ of lymph nodes, constantly, if the immune system were required to do that.”
如果我們經常接觸棉花糖的淋巴結，那麼我們就不可能一直保持高水平的免疫，因為我們需要棉花糖的淋巴結保持高水平的免疫。”
Why Are Natural Immunity, Early Treatment Protocols Censored?
為什麼要審查（封鎖）自然免疫和早期治療方案？
Dr. Peter McCullough is an internist, cardiologist, epidemiologist and full professor of medicine at Texas A&M College of Medicine in Dallas. He also has a master’s degree in public health and is known for being one of the top five most-published medical researchers in the U.S. and is the editor of two medical journals.
Peter McCullough博士是達拉斯德克薩斯A&M醫學院的內科醫生、心臟病學家、流行病學家和醫學教授。他還擁有公共衛生碩士學位，是美國五大出版最多的醫學研究者之一，也是兩種醫學期刊的編輯。
In our recent interview, he discussed the importance of early treatment for COVID-19, and the potential motivations behind the suppression of safe and effective treatments. He also told Horowitz, “[T]here has never been a confirmed second [COVID-19] infection beyond 90 days with similar or worse cardinal symptoms and confirmed PCR/Antigen/Sequencing test.”(23)
在我們最近的採訪中，他討論了早期治療COVID-19的重要性，以及抑制安全有效治療的潛在動機。他還告訴霍洛維茨，“在90天之後，從未出現過第二次確診的[COVID-19]感染，其主要症狀相似或更糟，並經PCR/抗原/測序試驗證實。”
In August 2020, McCullough’s landmark paper “Pathophysiological Basis and Rationale for Early Outpatient Treatment of SARS-CoV-2 Infection” was published online in the American Journal of Medicine.(24) The follow-up paper, titled “Multifaceted Highly Targeted Sequential Multidrug Treatment of Early Ambulatory High-Risk SARS-CoV-2 Infection (COVID-19),” was published in Reviews in Cardiovascular Medicine in December 2020.(25)
2020年8月，McCullough的里程碑式論文《SARS-CoV-2感染早期門診治療的病理生理學基礎和理論基礎》在《美國醫學雜誌》上在線發表。（24）後續論文，題為“早期非臥床高危SARS-CoV-2感染（COVID-19）的多方面高靶向序貫多藥治療”於2020年12月在《心血管醫學評論》上發表。（25）
While early treatment options were available when the pandemic began, patients were simply told to stay home and do nothing, until the infection had progressed to the point where they were having trouble breathing. Once at the hospital, COVID patients were routinely placed on mechanical ventilation — a practice that was quickly discovered to be lethal.
雖然大流行開始時可以選擇早期治療，但患者只被告知呆在家裡，什麼也不做，直到感染發展到呼吸困難的程度。一旦到了醫院，COVID患者就被例行地進行機械通氣——這種做法很快被發現是致命的。
But McCullough has been an outspoken advocate for early treatment for COVID, as have other pioneering doctors like those behind the MATH+ protocol. He believes the end goal in suppressing early treatment was to secure the rollout of a mass vaccination campaign.
但是McCullough一直是一位直言不諱的COVID早期治療的倡導者，其他像MATH+協議背後的先驅醫生也是如此。他認為，抑制早期治療的最終目標是確保大規模疫苗接種運動的開展。
Indeed, effective treatments like ivermectin — a broad-spectrum antiparasitic that also has anti-inflammatory activity — have shown remarkable success in preventing and treating COVID-19,(26) but they continue to be ignored in favor of more expensive, and less effective, treatments and mass experimental vaccination.(27)
事實上，伊維菌素（一種廣譜抗寄生蟲藥，也具有抗炎活性）等有效治療方法在預防和治療COVID-19方面取得了顯著的成功，（26），但它們仍然被忽視，轉而採用更昂貴、更低效的治療和大規模實驗性疫苗接種
At this point, however, with effective treatments available, the documented high survival rate of COVID-19 (28) and knowledge that if you’ve had COVID-19, you’re already likely immune to further infection, the rationale for getting vaccinated is faltering. Even the Delta variant has a very low 0.2% case fatality rate in the U.K., which drops to 0.03% in those under 50.(29)
然而，在這一點上，有了有效的治療，有文獻記載的COVID-19（28）的高存活率，以及如果你已經感染了COVID-19，你可能已經對進一步的感染免疫，接種疫苗的理由正在動搖。即使Delta變異體在英國的病死率非常低，在50歲以下的患者中死亡率也下降到0.03%。（29）
Natural Infection Will ‘Burn Out All Variants’
自然感染會“燒毀所有變種”
If you choose to get a COVID-19 vaccine, you’re participating in an unprecedented experiment with an unapproved gene therapy, of which the benefits may not outweigh the risks, especially if you’ve already had COVID-19 and are already likely immune.
如果你選擇接種COVID-19疫苗，你將參與一項前所未有的未經批准的基因治療實驗，其好處可能不會超過風險，特別是如果你已經接種了COVID-19疫苗並且可能已經免疫的話。
As noted by Horowitz, “Natural infection is the only phenomena that will ultimately burn out all variants, and the entire focus should be on getting seniors and other vulnerable people early treatment the minute they feel symptoms and even a prophylactic regimen of ivermectin … when appropriate.”(30)
正如霍洛維茨所指出的，“自然感染是最終消滅所有變種的唯一現象，整個重點應該是讓老年人和其他易受感染的人在感到症狀的那一刻儘早接受治療，甚至在適當的情況下採取伊維菌素預防方案。”(30)
Meanwhile, McCullough pointed out that by getting vaccinated, you’re setting yourself up for a very narrow immunity — much unlike the broad naturally acquired immunity — that could be easily overwhelmed by a more virulent virus. As he said in our interview that I previously mentioned:
與此同時，McCullough指出，通過接種疫苗，你正在為自己建立一種非常狹隘的免疫力——與廣泛的自然獲得免疫力大不相同——這種免疫力很容易被一種毒性更強的病毒壓倒。正如他在我們的採訪中所說，我之前提到：
“What I know based on the literature right now is there could be a risk given the narrow spectrum of immunologic coverage … There could be such a narrow immunity that more virulent strain could overwhelm it …
“根據目前的文獻，我所知道的是，鑑於免疫覆蓋範圍狹窄，可能存在風險……可能存在如此狹窄的免疫範圍，以至於更致命的菌株可能會壓倒它…
The most recent variant is the Delta variant. That’s the weakest of all the variants and the most easily treatable. But if someone, let’s say a nefarious entity created a more virulent virus, it could easily be designed to scoot past a very narrow immunity that hundreds of millions, if not billions of people, will be keyed to with narrow immunity.”
最新的變體是Delta變體。這是所有變種中最弱的，也是最容易治療的。但是，如果有人，比如說一個邪惡的實體創造了一種毒性更強的病毒，它很容易被設計成通過一個非常狹窄的免疫系統，而數億人（如果不是數十億人）將被狹隘的免疫系統所控制。”
**By Dr. Joseph Mercola
**約瑟夫·梅科拉博士
**Source
留言